| AMG 334 20160172 Pediatric Migraine PK Study. (NCT03499119) | Amgen | 2018-05-04 |
| A Phase III Trial of e-TNS for the Acute Treatment of Migraine (NCT03465904) | Cefaly Technology | 2018-04-10 |
| Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis (NCT04463875) | Corfu Headache Clinic | 2018-04-01 |
| Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine (NCT03488563) | AOBiome LLC | 2018-03-30 |
| Pain Biomarker Study (NCT03511846) | The University of Texas Health Science Center, Houston | 2018-03-21 |
| The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users (NCT03335163) | University of Colorado, Denver | 2018-03-15 |
| Efficacy of OnabotulinumtoxinA in Migraine (NCT04578782) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2018-03-13 |
| Therapeutic Ultrasound in the Treatment of Migraine (NCT03459495) | Bursa Yuksek Ihtisas Training and Research Hospital | 2018-03-10 |
| Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine (NCT03398668) | Neurolief Ltd. | 2018-02-22 |
| The Effect of Sumatriptan and Placebo on CGRP Induced Headache (NCT03542357) | Danish Headache Center | 2018-02-15 |
| A Study Investigating the Efficacy of GON Blocks. (NCT04017741) | Barts & The London NHS Trust | 2018-02-14 |
| Sensitivity to Acute Cerebral Ischemia in Migrainers (NCT03301441) | University Hospital, Montpellier | 2018-02-09 |
| Effects of MTRPs Therapy in Migraine. (NCT05646160) | Józef Piłsudski University of Physical Education | 2018-01-15 |
| Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine (NCT03303079) | Otsuka Pharmaceutical Co., Ltd. | 2017-12-19 |
| Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine (NCT03303092) | Otsuka Pharmaceutical Co., Ltd. | 2017-12-19 |
| Plasma Levels of CGRP and Expression of Specific microRNAs in Blood Cells of Episodic and Chronic Migraine Subjects (NCT04473976) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2017-12-15 |
| Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine (NCT03303105) | Otsuka Pharmaceutical Co., Ltd. | 2017-12-07 |
| (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist (NCT03381261) | Massachusetts General Hospital | 2017-12-01 |
| Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE (NCT03275922) | Impax Laboratories, LLC | 2017-11-27 |
| A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine (NCT03282227) | Zosano Pharma Corporation | 2017-11-07 |
| Greater Occipital Nerve Block Versus Metoclopramide (NCT03269435) | Montefiore Medical Center | 2017-11-01 |
| The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache (NCT03422796) | Danish Headache Center | 2017-11-01 |
| RELAXaHEAD for Headache Patients (Phase I) (NCT03183791) | NYU Langone Health | 2017-11-01 |
| Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine (NCT03280342) | University of Minnesota | 2017-10-30 |
| CHOCOlate MeLatonin for AdolescenT MigrainE (NCT03597529) | Amy Gelfand | 2017-09-25 |
| Introvision for Migraine and Headaches (NCT03507400) | Ludwig-Maximilians - University of Munich | 2017-09-20 |
| A Pilot Study of Creative Arts Interventions for Neurology Inpatients (NCT03520777) | Dartmouth-Hitchcock Medical Center | 2017-09-19 |
| Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions. (NCT03083860) | Brainmarc Ltd. | 2017-09-01 |
| Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief (NCT03263897) | Caps Research Network | 2017-08-21 |
| Abortive Treatment of Migraine With the Cefaly® Abortive Program Device (NCT03217968) | Cefaly Technology | 2017-08-10 |
| Melatonin for Adolescent Migraine Prevention Study (NCT03150797) | Amy Gelfand | 2017-08-02 |
| Longitudinal Changes of Brain Functional Connectivity in Migraine (NCT03487978) | Samsung Medical Center | 2017-07-24 |
| A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine. (NCT03185559) | Neurolief Ltd. | 2017-07-23 |
| Effectiveness and Neural Mechanism of Naoan Dripping Pills for Migraine (NCT03175900) | Dongzhimen Hospital, Beijing | 2017-06-17 |
| China Headache and Vertigo Registry Study (NCT04939922) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2017-06-12 |
| Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects (NCT03282838) | Dr. Reddy's Laboratories Limited | 2017-06-09 |
| Integrative Migraine Pain Alleviation Through Chiropractic Therapy (NCT03177616) | Harvard University Faculty of Medicine | 2017-06-07 |
| Migraine Prevention Using ActiPatch (NCT03166046) | BioElectronics Corporation | 2017-06-01 |
| LSFG-SKIN, Laser Speckle Flowgraphy (NCT03660618) | Randy Kardon | 2017-05-23 |
| Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers (NCT03156920) | Danish Headache Center | 2017-05-23 |
| Infants Colics : Towards a Migrainous Origin ? (NCT03155360) | Central Hospital, Nancy, France | 2017-05-18 |
| Energy for the Brain (NCT03132233) | University Hospital, Basel, Switzerland | 2017-05-08 |
| BrainCool-Migraine Intranasal Cooling Trial (NCT03167060) | Cumbria Partnership NHS Foundation Trust | 2017-05-08 |
| A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks (NCT03159000) | Thomas Jefferson University | 2017-05-01 |
| Migraine and CVD Risk in Women (NCT03081390) | University of Pennsylvania | 2017-04-01 |
| Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function (NCT03009162) | Eli Lilly and Company | 2017-04-01 |
| Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness (NCT02791893) | Benjamin Natelson | 2017-03-21 |
| Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants (NCT03076970) | Eli Lilly and Company | 2017-03-21 |
| Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function (NCT03040479) | Eli Lilly and Company | 2017-03-14 |
| Mindfulness and Migraine Research Study (NCT02824250) | California Pacific Medical Center Research Institute | 2017-03-09 |
| The Effects of Caffeine Withdrawal on Migraine (NCT03022838) | Nordlandssykehuset HF | 2017-02-28 |
| A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine (NCT02959190) | Eli Lilly and Company | 2017-02-07 |
| The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants (NCT03012334) | Eli Lilly and Company | 2017-01-16 |
| The MOTS (Medication Overuse Treatment Strategy) Trial (NCT02764320) | Mayo Clinic | 2017-01-09 |
| Very Low Calories Ketogenic Diet in Migraine. (NCT03076060) | University of Roma La Sapienza | 2017-01-01 |
| Diary-based Study on the Course of Hormone-withdrawal Migraines (NCT04012593) | University of Zurich | 2017-01-01 |
| Near Death Experience (NDE) and Migraine (NCT02854930) | Assistance Publique Hopitaux De Marseille | 2017-01-01 |
| Oral Dexamethasone for the Treatment of Acute Migraine Recurrence in the Pediatric Emergency Department (NCT02794441) | Children's Hospital of Eastern Ontario | 2016-12-01 |
| Status Migrainosus - Differentiating Between Responders and Non-responders (NCT03066544) | Hartford HealthCare | 2016-11-30 |
| A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine (NCT02959177) | Eli Lilly and Company | 2016-11-09 |
| The Functional Magnetic Resonance Imaging Study on the Processing of Acute Pain and Cognition Among Perimenopause Women (NCT02820974) | Tang-Du Hospital | 2016-11-01 |
| Migraine Prophylaxis With Clopidogrel Trial (NCT02938182) | First Affiliated Hospital Xi'an Jiaotong University | 2016-10-01 |
| Corticosteroids for Acute Migraine in the Emergency Department (NCT02847494) | Montefiore Medical Center | 2016-09-01 |
| A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder (NCT02905227) | Acorda Therapeutics | 2016-09-01 |
| Mindfulness and Mechanisms of Pain Processing in Adults With Migraines (NCT02695498) | Wake Forest University Health Sciences | 2016-08-26 |
| CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment (NCT03481400) | Danish Headache Center | 2016-07-01 |
| A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine (NCT02784847) | University of Liege | 2016-06-01 |
| Yoga for Chronic Headache in Adolescents (NCT02721849) | Universität Duisburg-Essen | 2016-04-01 |
| Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine (NCT02629861) | Teva Branded Pharmaceutical Products R&D, Inc. | 2016-03-23 |
| Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine (NCT02621931) | Teva Branded Pharmaceutical Products R&D, Inc. | 2016-03-22 |
| Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers (NCT02954276) | Targia Pharmaceuticals Ltd. | 2016-03-01 |
| Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine (NCT02638103) | Teva Branded Pharmaceutical Products R&D, Inc. | 2016-02-26 |
| Ketamine v. Ketorolac for Management of Generalized Tension Type Headache (NCT03221569) | The Brooklyn Hospital Center | 2016-02-01 |
| Acute Treatment of Migraine With e-TNS (NCT02590939) | Cefaly Technology | 2016-02-01 |
| Metformin for the Prevention of Episodic Migraine (MPEM) (NCT02593097) | Mayo Clinic | 2016-02-01 |
| Efficacy and Safety of Danzhen (NCT02645370) | Xijing Hospital | 2016-02-01 |
| A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention (NCT02630459) | Amgen | 2016-01-06 |
| Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Refractory Migraine (NCT03125525) | Corfu Headache Clinic | 2016-01-01 |
| RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks (NCT02686034) | ElectroCore INC | 2016-01-01 |
| Salivary Inflammatory Markers in Tension Type Headache and Migraine (NCT03727672) | National and Kapodistrian University of Athens | 2016-01-01 |
| Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study (NCT02614196) | Eli Lilly and Company | 2015-12-04 |
| An Exploratory Prospective Trial of Rescue Acupuncture for the Treatment of Acute Migraine (NCT02764996) | Mike O'Callaghan Military Hospital | 2015-12-01 |
| A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura (NCT02614287) | Eli Lilly and Company | 2015-11-30 |
| To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients (NCT02542605) | Amgen | 2015-11-11 |
| TRiptan Use and Serious Vascular Events in Elderly Over 65 Years (NCT02838537) | Assistance Publique Hopitaux De Marseille | 2015-11-01 |
| Abortive Effect of an Ear Insufflator on Migraine (NCT02614378) | Carrick Institute for Graduate Studies | 2015-11-01 |
| Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults (NCT02609945) | Acorda Therapeutics | 2015-11-01 |
| Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks (NCT02583581) | Brainmarc Ltd. | 2015-10-01 |
| Ticagrelor Therapy for RefrACTORy Migraine Study (NCT02518464) | Columbia University | 2015-10-01 |
| The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients (NCT02532023) | Tehran University of Medical Sciences | 2015-09-01 |
| Transcriptomic and Biochemical Changes During a Migraine Attack (NCT02468622) | Danish Headache Center | 2015-08-01 |
| Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention (NCT02483585) | Amgen | 2015-07-20 |
| Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention (NCT02456740) | Amgen | 2015-07-17 |
| Bronx MBCT-Migraine (NCT02443519) | Albert Einstein College of Medicine | 2015-07-01 |
| Greater Occipital Nerve Block With Bupivacaine for Acute Migraine (NCT02665273) | Montefiore Medical Center | 2015-07-01 |
| Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children (NCT02358681) | Columbia University | 2015-06-16 |
| Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches (NCT02472418) | Dr. Reddy's Laboratories Limited | 2015-06-05 |
| A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine (NCT02378844) | ElectroCore INC | 2015-06-01 |
| Prospective Analgesic Compound Efficacy (PACE) Study (NCT02403687) | Express Specialty Pharmacy | 2015-06-01 |
| Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population (NCT02425696) | Yingqi Xing | 2015-06-01 |